Europe · Regional markets · L'Agefi Suisse

La FDA homologue une version améliorée du test Cobas de Roche

Published by L'Agefi Suisse · Switzerland 13 h ago

Le test permet de détecter jusqu’à 19 virus et bactéries à partir d’un seul prélèvement, dont le virus de la grippe A, le virus respiratoire syncytial et le SARS-CoV-2.

Read the full article on L'Agefi Suisse Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (agefi.com)

Also worth reading

City A.M.

Anthropic’s growth slows ahead of IPO as AI spending bill nears $900bn

This is Money

Economist who predicted last two housing crashes warns the market is already in freefall. Your home's value could plummet by £82,000 - here's what to do to protect yourself

Finews

La FDA homologue une version améliorée du test Cobas de Roche

Share

Also worth reading

Anthropic’s growth slows ahead of IPO as AI spending bill nears $900bn

Economist who predicted last two housing crashes warns the market is already in freefall. Your home's value could plummet by £82,000 - here's what to do to protect yourself

Fund market: most fresh money flows into bonds

Rentokil Initial & Everyman Media: Big director share deals

China is a technology powerhouse: how can you gain exposure?

Rabobank letterlijk steeds meer uit beeld verdwenen